ENCORE Introduces Innovative Beverage Mixes Featuring Science-Backed Cognizin® and IMMUSE™ for Cogni
news via All Health
Kyowa Hakko's Cognizin® Citicoline, and postbiotic, IMMUSE™, infuse their cutting-edge components in the new product line. NEW YORK , April 18, 2024 /PRNewswire-PRWeb/ -- Kyowa Hakko U.S.A., Inc. announces the inclusion of its science-backed branded ingredients Cognizin® and IMMUSE™ in...
READ FULL ARTICLE »
Become a member to take advantage of more features, like commenting and voting.
Register or sign in today!